Cargando…

Age-specific and sex-specific risks for HCC in African-born persons with chronic hepatitis B without cirrhosis

BACKGROUND: The international recommendations of HCC surveillance for African-born persons with chronic hepatitis B (CHB) without cirrhosis are divergent, probably due to scarce data on incidence rate (IR) for HCC. METHODS: We assembled a cohort with prospectively collected data of Swedish residents...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamal, Habiba, Ingre, Michael, Stål, Per, Westman, Gabriel, Bruce, Daniel, Wedemeyer, Heiner, Duberg, Ann-Sofi, Aleman, Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697596/ http://dx.doi.org/10.1097/HC9.0000000000000334

Ejemplares similares

Circulating Cytokines Reflect the Etiology-Specific Immune Environment in Cirrhosis and HCC
por: Beudeker, Boris J. B., et al.
Publicado: (2022)

Prospects and Challenges for T Cell-Based Therapies of HCC
por: Woller, Norman, et al.
Publicado: (2021)

Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County
por: Gahrton, Caroline, et al.
Publicado: (2019)

HCC: RNA-Sequencing in Cirrhosis
por: Wang, Haoyu, et al.
Publicado: (2023)

The sex‐specific prognostic utility of sarcopenia in cirrhosis
por: Lowe, Ryan, et al.
Publicado: (2022)

Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study
por: Duberg, Ann‐Sofi, et al.
Publicado: (2022)

Reply
por: Duberg, Ann‐Sofi, et al.
Publicado: (2022)

HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level
por: Willuweit, Katharina, et al.
Publicado: (2020)

Hepatitis C time trends in reported cases and estimates of the hidden population born before 1965, Denmark and Sweden, 1990 to 2020
por: Christensen, Peer Brehm, et al.
Publicado: (2022)

The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population‐based cohort study
por: Bengtsson, Bonnie, et al.
Publicado: (2022)

Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis
por: Ismail, Saber A, et al.
Publicado: (2017)

Diabetes and the risk of cirrhosis and HCC: An analysis of the UK Biobank
por: Ye, Fangzhou, et al.
Publicado: (2023)

Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
por: Sun, Na, et al.
Publicado: (2020)

Monitoring the progress towards the elimination of hepatitis B and C in Sweden: estimation of core indicators for 2015 and 2018
por: Colombe, Soledad, et al.
Publicado: (2022)

Progression of liver cirrhosis to HCC: an application of hidden Markov model
por: Bartolomeo, Nicola, et al.
Publicado: (2011)

Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients
por: Lybeck, Charlotte, et al.
Publicado: (2019)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis
por: Tergast, Tammo L., et al.
Publicado: (2023)

Gender disparity in HCC: Is it the fat and not the sex?
por: Greten, Tim F.
Publicado: (2019)

Sex-specific changes in triglyceride profiles in liver cirrhosis and hepatitis C virus infection
por: Peschel, Georg, et al.
Publicado: (2022)

Mortality among amphetamine users with hepatitis C virus infection: A nationwide study
por: Gahrton, Caroline, et al.
Publicado: (2021)

Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2020)

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19
por: Blach, Sarah, et al.
Publicado: (2021)

Reply to: “Reduced steatosis and weight as a result of specific diets or the dietitian themselves”
por: Holmer, Magnus, et al.
Publicado: (2021)

Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns
por: Soresi, Maurizio, et al.
Publicado: (2017)

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Zanetto, Alberto, et al.
Publicado: (2021)

Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
por: Huang, Daniel Q., et al.
Publicado: (2022)

Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions
por: Healy, Katie, et al.
Publicado: (2021)

Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans
por: Gustafson, Callie M, et al.
Publicado: (2015)

Sex‐specific analysis of microRNA profiles in HBV‐associated cirrhosis by small RNA‐sequencing
por: Chan, Kristy Kwan‐Shuen, et al.
Publicado: (2022)

Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma
por: Zenlander, Robin, et al.
Publicado: (2021)

Establishment of monoclonal HCC cell lines with organ site-specific tropisms
por: Wan, Jinliang, et al.
Publicado: (2015)

Nosocomial infections in female compared with male patients with decompensated liver cirrhosis
por: Griemsmann, Marie, et al.
Publicado: (2022)

Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study
por: Wester, Axel, et al.
Publicado: (2023)

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
por: Jiang, Yingying, et al.
Publicado: (2020)

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC
por: Abed, Sally, et al.
Publicado: (2017)

Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
por: Zhang, Ping, et al.
Publicado: (2018)

Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis
por: Ahmed, Moiz, et al.
Publicado: (2021)

Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials
por: Kraglund, Frederik, et al.
Publicado: (2023)

Sex-specific association between alcohol consumption and liver cirrhosis: An updated systematic review and meta-analysis
por: Llamosas-Falcón, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hfd62qasppf87hmil5v0mt42qe